Skip to search.
 FTSE 100 Down 1.00%

More On GLAXF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GLAXF)

-Other OTC
19.79 Up 0.28(1.46%) 15:05
Prev Close:19.50
Open:19.79
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:1.19947
Next Earnings Date:N/A
Day's Range:19.79 - 19.79
52wk Range:18.45 - 24.75
Volume:1,200
Avg Vol (3m):5,515
Market Cap:95.76b
P/E (ttm):7.88
EPS (ttm):2.51
Div & Yield:1.33 (6.39%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.22
P/S (ttm):2.71
Ex-Dividend Date:18-Feb-16

Analysts

Annual EPS Est (Dec-16) :84.35
Quarterly EPS Est (Mar-16) :18.07
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):4.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback